Who are ForteBio's investors?

ForteBio's investors include Latterell Venture Partners, MPM BioImpact, OrbiMed, The Vertical Group, Versant Ventures.

ForteBio

acquired by Pall

6 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the ForteBio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Developed biotech research instruments for measuring molecular binding; acquired by Pall Corporation for $159M.

Agilent Ventures

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

2 people who came through ForteBio went on to found or lead other companies.

What does ForteBio do?: Developed biotech research instruments for measuring molecular binding; acquired by Pall Corporation for $159M.
Who are ForteBio's investors?: ForteBio's investors include Latterell Venture Partners, MPM BioImpact, OrbiMed, The Vertical Group, Versant Ventures.
Who acquired ForteBio?: ForteBio was acquired by Pall.